Literature DB >> 23465020

Pneumocystis pneumonia in solid organ transplantation.

S I Martin1, J A Fishman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23465020     DOI： 10.1111/ajt.12119

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  48 in total

Review 1.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

2.  Update on Chronic Lung Allograft Dysfunction.

Authors:  Jason M Gauthier; Ramsey R Hachem; Daniel Kreisel
Journal:  Curr Transplant Rep       Date:  2016-08-02

Review 3.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

Review 4.  Fungal Infections After Lung Transplantation.

Authors:  Cassie C Kennedy; Raymund R Razonable
Journal:  Clin Chest Med       Date:  2017-05-20       Impact factor: 2.878

5.  m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis.

Authors:  Maryam Ghadimi; Zinat Mohammadpour; Simin Dashti-Khavidaki; Alireza Milajerdi
Journal:  Eur J Clin Pharmacol       Date:  2019-08-03       Impact factor: 2.953

6.  Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit.

Authors:  Guillaume Desoubeaux; Manon Dominique; Florent Morio; Rose-Anne Thepault; Claire Franck-Martel; Anne-Charlotte Tellier; Martine Ferrandière; Christophe Hennequin; Louis Bernard; Ephrem Salamé; Éric Bailly; Jacques Chandenier
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

7.  Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients.

Authors:  K F Urbancic; F Ierino; E Phillips; P F Mount; A Mahony; J A Trubiano
Journal:  Am J Transplant       Date:  2017-10-03       Impact factor: 8.086

8.  In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.

Authors:  E M Aliouat; E Dei-Cas; N Gantois; M Pottier; C Pinçon; S Hawser; A Lier; D B Huang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-12       Impact factor: 3.267

9.  Adjunctive glucocorticoid therapy for non-HIV-related pneumocystis carinii pneumonia (NH-PCP).

Authors:  J A McKinnell; A P Cannella; P Injean; A Gregson
Journal:  Am J Transplant       Date:  2014-02-19       Impact factor: 8.086

10.  Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study.

Authors:  Giannina Ricci; Daniel Wagner Santos; Joseph A Kovacs; Angela Satie Nishikaku; Taina Veras de Sandes-Freitas; Anderson Messias Rodrigues; Geetha Kutty; Regina Affonso; Hélio Tedesco Silva; José Osmar Medina-Pestana; Marcello Fabiano de Franco; Arnaldo Lopes Colombo
Journal:  Mycoses       Date:  2018-07-27       Impact factor: 4.377
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.